RECRUITING

Study of Patients Being Treated With Anti-obesity Medication

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this observational study is to learn about the real-world effects of selected obesity medications in adults undergoing medical weight management. The main outcomes of interest are changes in body composition, routine clinical markers, muscular performance, and nutritional intake over the course of treatment. Additionally, the influence of lifestyle factors on changes in these outcome variables will be examined. Participants beginning treatment with selected obesity medications will undergo periodic body composition and muscular performance testing, as well as complete online surveys about their nutritional intake and physical activity and exercise participation. Additionally, routinely collected clinical information will be evaluated.

Official Title

Observational Study of Patients Being Treated With Anti-obesity Medication

Quick Facts

Study Start:2025-01-31
Study Completion:2027-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06790160

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patient who is beginning treatment through Vineyard Virtual Health Clinic using semaglutide or tirzepatide. While the physician will individualize the treatment plans, the criteria for these medications will include, at a minimum: (A) a body mass index ≥30 kg/m2; OR (B) a BMI ≥27 kg/m2 plus at least one comorbidity.
  2. * Patient who lives in drivable proximity to a city with an accepted DXA testing facility and is willing to report to the facility for periodic body composition testing.
  1. * Patients with type 2 diabetes.
  2. * Patients who report not being willing or able to complete the assessments included in this research study.
  3. * Patients who are currently pregnant or trying to become pregnant.

Contacts and Locations

Study Contact

Grant Tinsley, Ph.D.
CONTACT
806-834-5895
grant.tinsley@ttu.edu

Study Locations (Sites)

Texas Tech University
Lubbock, Texas, 79409
United States

Collaborators and Investigators

Sponsor: Texas Tech University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-31
Study Completion Date2027-02

Study Record Updates

Study Start Date2025-01-31
Study Completion Date2027-02

Terms related to this study

Keywords Provided by Researchers

  • obesity
  • GLP-1
  • body composition
  • nutrition
  • exercise

Additional Relevant MeSH Terms

  • Obesity and Overweight